Skip to content

Cardio Training of Older Adults With Central Obesity

Cardio Training of Older Adults With Central Obesity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03450655
Enrollment
80
Registered
2018-03-01
Start date
2018-02-09
Completion date
2018-09-28
Last updated
2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visceral Obesity

Brief summary

Given the increasing prevalence of obesity, there is an urgent need to find better strategies to promote physical activity in the community. The present study will invite 70-year-olds with central (abdominal) obesity to participate in a 10-week aerobic exercise program. Participants will be randomly assigned to one of two equally large groups. The first group will complete the exercise program in instructor-led groups. The second group will complete the program at home with the help of an on-line video.

Detailed description

Central obesity means having a lot visceral fat, that is, fat located in the abdominal cavity. Visceral fat is a well-established risk factor for cardiovascular disease and all-cause mortality. Participants will be recruited from the Healthy Ageing Initiative (HAI), an ongoing population-based study that invites all 70-year-olds in Umeå, Sweden, to a health examination. The exercise program will focus is on station-based aerobic exercises and resistance exercises, predominantly with participants' own body weight as resistance. The program is progressive, starting at a moderate pace so that participants learn to perform the exercises properly. The intensity will be aimed at 60-80% of maximal exhaustion, and each exercise bout will last 60 seconds with 20 seconds of rest between bouts. The program was developed by seniors in the bachelor's program in exercise physiology at Umeå University, Sweden.

Interventions

OTHER10-week aerobic exercise program

An aerobic exercise program consisting of 45-60 minute sessions 3 times a week for 10 weeks.

Sponsors

Umeå University
CollaboratorOTHER
Region Västerbotten
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The Data Analyst will also be masked.

Eligibility

Sex/Gender
ALL
Age
70 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Participated in the Healthy Ageing Initiative (a population-based intervention study in Umeå, Sweden) * Visceral adipose tissue mass \>1 kg (women) or \>2 kg (men)

Exclusion criteria

* Physical disability that affects ability to perform the exercises * Heart failure or severe degenerative condition (e.g. malignant cancer or multiple sclerosis) * Myocardial infarction or stroke in the past year * Heart condition that can worsen with aerobic exercise (e.g. angina)

Design outcomes

Primary

MeasureTime frameDescription
Change in visceral adipose tissue mass0, 10, 20, and 31 weeksMass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA).

Secondary

MeasureTime frameDescription
Change in Body Mass Index (kg/m^2)0, 10, 20, and 31 weeks
Change in blood pressure (mmHg)0, 10, 20, and 31 weeksTaken after 15 min of rest
Change in blood-lipid profile0, 10, 20, and 31 weeks
Change in fasting blood glucose0, 10, 20, and 31 weeksVeinous blood samples taken after \> 4 h of fasting
Change in isometric muscle strength0, 10, 20, and 31 weeksMeasured in non-dominant hand with dynamometer (Jamar, Lafayette Instrument, USA). The better of two successive trials will be recorded.
Change in physical capacity0, 10, 20, and 31 weeksMeasured using Åstrands Submaximal Test, performed on an electrically braked ergometer bicycle
Change in body composition0, 10, 20, and 31 weeksMass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA)
Change in health-related quality of life0, 10, 20, and 31 weeksAs measured by RAND-36
Change in self-reported physical activity0, 10, 20, and 31 weeksAssessed using IPAQ-SF
Change in Microbiota composition0, 10, 20, and 31 weeksFecal samples are taken and bacterial DNA is sequenced to determine bacterial composition
Change in dietary habits0, 10, 20, and 31 weeks85 item food frequency questionnaire
Change in concentration of inflammatory markers0, 10, 20, and 31 weeks
Change in resting metabolic rate0, 10, 20, and 31 weeksAs measured by indirect calorimetry

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026